Showing results (501-510 of 581) with videos related to
Sort By:
Pageof 59
British Journal of Haematology|December 1, 1989
Slow evolution of chronic myeloid leukaemia relapsing after BMT with T-cell depleted donor marrowT P Hughes, K Economou, S Mackinnon, et al.Experimental Hematology|June 1, 1990
Bone marrow transplantation for chronic myeloid leukemia: the use of histocompatible unrelated volunteer donorsS Mackinnon, J M Hows, J M Goldman, et al.Genes, Chromosomes & Cancer|September 17, 1998
A two-color BCR-ABL probe that greatly reduces the false positive and false negative rates for fluorescence in situ hybridization in chronic myeloid leukemiaF H Grand, A Chase, S Iqbal, et al.The Journal of Infection|November 1, 1985
Ceftazidime as first-line therapy for fever in acute leukaemiaJ P Donnelly, R E Marcus, J M Goldman, et al.Blood|July 13, 2000
Estimating leukemia-free survival after allografting for chronic myeloid leukemia: a new method that takes into account patients who relapse and are restored to complete remissionC Craddock, R M Szydlo, J P Klein, et al.Bone Marrow Transplantation|March 30, 2001
Peripheral blood progenitor cell mobilisation alters myeloid, but not erythroid, progenitor cell self-renewal kineticsS B Marley, J L Lewis, B Zheng, et al.Leukemia|June 18, 2004
Efficacy of dual-specific Bcr-Abl and Src-family kinase inhibitors in cells sensitive and resistant to imatinib mesylateA J Tipping, S Baluch, D J Barnes, et al.Lancet (London, England)|February 15, 1975
Granulocyte transfusions in treatment of infections in patients with acute leukaemia and aplastic anaemiaR M Lowenthal, L Grossman, J M Goldman, et al.Blood|December 1, 1986
Histocompatible unrelated volunteer donors compared with HLA nonidentical family donors in marrow transplantation for aplastic anemia and leukemiaJ M Hows, J L Yin, J Marsh, et al.Cancer Research|November 3, 2001
Direct relation between BCR-ABL tyrosine kinase activity and cyclin D2 expression in lymphoblastsM W Deininger, S A Vieira, Y Parada, et al.Pageof 59